The invention proposes a new approach to rare genetic diseases for which no cures are available, only symptomatic treatments through the preparation of novel multivalent molecules active toward the human enzymes responsible for them
Research Institution:
Università degli Studi di Firenze
Priorities and sectors:
Life Sciences
